 | Up a level |
Lensen, Sarah; Paramanandam, Vincent S; Gabes, Michaela; Kann, Gesina; Donhauser, Theresa; Waters, Niamh F; Li, Anna D; Peate, Michelle; Susanto, Nipuni S; Caughey, Lucy E; Rangoonwal, Fatema; Liu, Jingbo; Condron, Patrick; Anagnostis, Panagiotis; Archer, David F; Avis, Nancy E; Bell, Robin J; Carpenter, Janet S; Chedraui, Peter; Christmas, Monica; ... (2024). Recommended measurement instruments for menopausal vasomotor symptoms: the COMMA (Core Outcomes in Menopause) consortium. Menopause, 31(7), pp. 582-590. The North American menopause Society 10.1097/GME.0000000000002370
Stute, Petra; Spyropoulou, Areti; Karageorgiou, Vasilios; Cano, Antonio; Bitzer, Johannes; Ceausu, Iuliana; Chedraui, Peter; Durmusoglu, Fatih; Erkkola, Risto; Goulis, Dimitrios G; Lindén Hirschberg, Angelica; Kiesel, Ludwig; Lopes, Patrice; Pines, Amos; Rees, Margaret; van Trotsenburg, Mick; Zervas, Iannis; Lambrinoudaki, Irene (2020). Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement. Maturitas, 131, pp. 91-101. Elsevier 10.1016/j.maturitas.2019.11.002
Pines, Amos; Sturdee, David; Birkhäuser, Martin (2008). Health risks after cessation of postmenopausal hormone therapy. Climacteric, 11(3), pp. 179-80. Abingdon, UK: Informa Healthcare 10.1080/13697130802176228
